Keywords: Valeant, ISTA Pharma, Hostile bid, Acquisiton, Alexza explores options, Ophthalmic products, Adasuve, Schizophrenia
ISTA Pharma rejects Valeant’s advances; Alexza could be for sale
Article | 19 December 2011
Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) has entered into another hostile takeover attempt, this time revealing that it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
